LDLR and metabolic disease: Its therapeutic effects in cardiovascular diseases and metabolic disorders have been clinically verified, and its molecular mechanisms of action have also been well illuminated28–31, e.g., BBR could reduce serum TDL and LDL cholesterol by stabilizing LDLR mRNA to post-transcriptionally increase LDLR expression32.